Reporting owner · CIK 0001193210

Cozadd Bruce C

Visual SEC Form 4 history across 1 companies, 10 transactions and 6 filings.

DIRJazz Pharmaceuticals plc
Open-market mix
Latest filingSep 02, 2026, 09:03 PM
Filings6Form 4 records
Buying$00 purchases
Selling$2.8M4 sales
Net value−$2.8MBuys minus sells
Companies11 securities
Most recentSep 01, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Jan 251Feb 251Mar 25Aug 261Sep 26

Net value flow

Buys minus sells

Jan 25
−$185.1K
Feb 25
−$183.5K
Mar 25
−$937.6K
Aug 26
$0
Sep 26
−$1.5M

Transaction texture

Ownership and ticket size

Average P/S size$701.8K
Median P/S size$561.4K
Direct10
Indirect0
Sep 01, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern1Direct Ownershipfiling-context7Repeat Sellerpattern110b5-1 Detectedfiling-context4

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Jazz Pharmaceuticals plc on Sep 01, 2026 valued at $1,500,780.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Jazz Pharmaceuticals plc on Sep 01, 2026 valued at $1,500,780.

Review SEC filing

Associated companies

Visual map of known reporting history

JAZZJazz Pharmaceuticals plc10 transactions · latest Sep 02, 2026, 09:03 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
JAZZCOZADD BRUCE C
DIR
sale10b5-16.00k-$150MS
Cluster Selling Direct Ownership Large Sale+1
0.0%09/0209/01
JAZZCOZADD BRUCE C
DIR
withholding10b5-11.20k-$29.1MF
Direct Ownership 10b5-1 Detected
0.0%09/0208/31
JAZZCOZADD BRUCE C
DIR
withholding10b5-110-$244kF
Direct Ownership 10b5-1 Detected
0.0%09/0208/31
JAZZCOZADD BRUCE C
CHAIRCEO
return22.2k-$309MD
Direct Ownership
—03/07/202503/05/2025
JAZZCOZADD BRUCE C
CHAIRCEO
sale10b5-16.50k-$93.7MS
Cluster Selling Direct Ownership Repeat Seller+1
—03/04/202503/03/2025
JAZZCOZADD BRUCE C
CHAIRCEO
grant10b5-130.8k$0A
Direct Ownership 10b5-1 Detected
—03/04/202502/27/2025
JAZZCOZADD BRUCE C
CHAIRCEO
sale10b5-11.50k-$18.3MS
Direct Ownership 10b5-1 Detected
—02/05/202502/03/2025
JAZZCOZADD BRUCE C
CHAIRCEO
withholding13.8k-$169MF
Direct Ownership
—01/22/202501/17/2025
JAZZCOZADD BRUCE C
CHAIRCEO
grant29.5k$0A
Direct Ownership
—01/22/202501/17/2025
JAZZCOZADD BRUCE C
CHAIRCEO
sale10b5-11.50k-$18.5MS
Direct Ownership 10b5-1 Detected
—01/06/202501/02/2025

Cozadd Bruce C Insider Activity FAQ

SEC Form 4 context

Who is Cozadd Bruce C?

Cozadd Bruce C is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001193210.

Which companies has Cozadd Bruce C reported transactions for?

Jazz Pharmaceuticals plc

When was Cozadd Bruce C's latest insider buy?

No open-market insider purchase is available for this period.

When was Cozadd Bruce C's latest insider sale?

sale at Jazz Pharmaceuticals plc on Sep 01, 2026 valued at $1,500,780.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.